Company Quick10K Filing
Rich Pharmaceuticals
10-K 2018-03-31 Filed 2018-07-17
S-1 2018-01-24 Public Filing
10-Q 2017-12-31 Filed 2018-02-20
10-Q 2017-09-30 Filed 2017-12-29
10-Q 2017-06-30 Filed 2017-12-06
10-K 2017-03-31 Filed 2017-09-05
10-Q 2016-12-31 Filed 2017-02-13
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-K 2016-03-31 Filed 2016-08-22
10-Q 2015-12-31 Filed 2016-02-22
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-09-25
10-K 2015-03-31 Filed 2015-09-17
10-Q 2014-12-31 Filed 2015-02-23
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-19
10-K 2014-03-31 Filed 2014-07-15
10-Q 2013-12-31 Filed 2014-02-19
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-19
10-K 2013-03-31 Filed 2013-07-01
10-Q 2012-06-30 Filed 2012-08-13
10-K 2012-03-31 Filed 2012-07-11
10-Q 2011-12-31 Filed 2012-03-09
8-K 2019-06-11
8-K 2019-02-12
8-K 2018-04-10
8-K 2018-03-15
8-K 2018-03-02
8-K 2018-02-09
8-K 2018-02-01
8-K 2018-01-18
8-K 2018-01-10
8-K 2018-01-02

Rich Pharmaceuticals Financials

RCHA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
US Stem Cell (USRM) 0 58% -0.2 -481% 656 9,770 2,763 1,598 -3,158 -2,256 378
Bravatek Solutions (BVTK) 0 73% 0.0 -158% 151 8,437 199 146 -239 -114 -2
Visium Technologies (VISM) 0 0.0 -31,116% 3 3,141 0 0 -796 -796 -3
Fiverr (FVRR)
Zenergy Brands (ZNGY) 0 17% 0.0 -171% 2,124 8,074 2,085 345 -3,635 -3,635 -6
Patriot Scientific (PTSC) 0 1.2 -41% 1,925 228 0 0 -798 -797 -986
Granite Real Estate (GRP)
Growlife (PHOT) 0 33% 0.0 -130% 4,626 9,064 6,744 2,193 -6,029 -4,695 -201
Dais Analytic (DLYT) 0 36% 0.0 -597% 414 8,700 1,055 378 -2,470 -2,184 -14
Jumia (JMIA)
Rich Pharmaceuticals (RCHA) 0 -6% 0.0 -4,521% 37 6,396 115 -7 -1,692 -2,356 -6
InMode (INMD)
View Systems (VSYM) 0 100% -0.8 -1,148% 27 1,083 1 1 -308 -272 226
Owl Rock Capital (ORCC)
Endonovo Therapeutics (ENDV) 0 73% -0.8 -301% 3,414 19,980 204 150 -10,268 -9,617 7,448
Link Motion (LKM) 0 0% 853,628 377,864 0 0 0 0 -91,397
Cerence (CRNC)
W&E Source (WESC) 0 100% 0.0 -419% 14 182 1 1 -60 -60 -3
Ford Motor Credit (FMCC) 0 0% 15.7 1% 160,883,000 146,728,000 12,691,000 0 2,313,000 7,242,000 114,027,000
Sirva (SRVA)

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash3012121242601018120461600300004142546
Accounts Receivable
Inventory
PP&E111111111433222211
Assets3012121242608448151036892463576325321573537
Accounts Payable1812481701839109169119811,1391,155351367350350312352327
Long-Term Debt38133
Liabilities01113151731972102138536181,0251,2161,7431,7631,9122,5782,3982,5182,7613,2085,3797,5305,3635,2466,396
Stockholders' Equity302-0-2-13-29-37-126-166-837-515-1,018-1,127-1,719-1,757-1,909-2,573-2,392-2,512-2,758-3,205-5,326-7,509-5,306-5,211-6,359
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Revenue0000000000000000000000011500
Cost of Revenue80818326046106101959522
Gross Profit-80-81-8-32-60-4-6-10-6-10-19-520-22
R&D72080007214819391
SG&A0000000
Tax0000000000000000000000000
Net Income-28-2-2-11-16-8-124-190-520-671-1,436-1,506-648-309-90189-178-267-540-2,256-2,3021,79655-1,242
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash Operating-21-1-4-14-13-6-165-91-81-352-398-284-411-142-89-112-152-132-58-98-264-176-118-76-139
Cash Investing-1-2300-1-3-10-503
Cash Financing14511641371009834040228642112689116151132589831514415455138